We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00916747
Recruitment Status : Enrolling by invitation
First Posted : June 9, 2009
Last Update Posted : July 19, 2017
Information provided by (Responsible Party):
Mark Kieran, Boston Children's Hospital